A

ADTX

Aditxt Inc

0.02

-0.01-39.82%
Suspension19:49 03/14 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE0.0347/0.0334
TODAY RANGE0.0200-0.0349
VOL240.20M
MARKET CAP1.59M
52 WEEK RANGE0.0200-218.00
AVG VOL (3M)88.49M
% TURNOVER304.47%
TURNOVER--
P/E (TTM)-0.0000
% RANGE44.61%
EPS(TTM)-1,248.1323
P/E(FORWARD)-0.0018
P/B0.0023
BVPS8.87
DIVIDEND--
P/S0.0010
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.59M
SHARES OUTSTANDING78.89M
NEXT EARNINGS04/14-04/18
FREE FLOAT78.89M
LOT SIZE1
EX-DIV DATE03/17/2025
News
Press Releases
Financial Reports
Profile
Latest
Popular
Same Industry
Name/Symbol
Change%
Price

A

Aditxt Inc

ADTX

-39.82%
0.0201

R

Regeneron Pharmaceuticals

REGN

-2.02%
666.87

E

Entero Therapeutics

ENTO

+2.12%
0.4820

B

BIONTECH

BNTX

+2.06%
99.47

U

United Therapeutics Corp.

UTHR

+0.61%
307.24

V

Vertex Pharmaceuticals Inc

VRTX

+0.37%
504.77

S

Siga Technologie

SIGA

+2.39%
5.58

M

Moderna

MRNA

+0.93%
34.62

C

Charles Riv Labs Intl Inc

CRL

+2.46%
171.04

M

Medpace Holdings

MEDP

+2.21%
324.95

T

Talphera Inc

TLPH

-0.89%
0.5600

I

ICON PLC

ICLR

+3.15%
184.58

C

China Biologic

CBPO

--
119.99

I

Iqvia Hldgs Inc

IQV

+2.07%
185.19

M

MOLECULAR PARTNERS AG

MOLN

-1.37%
4.33

A

Arcturus Therape

ARCT

+1.30%
14.08

G

Gilead Sciences Inc

GILD

-1.00%
111.44

P

PRA Health

PRAH

--
165.21

I

Incyte Corp

INCY

+0.22%
67.86

A

Aptevo Therapeutics Inc

APVO

+1.26%
2.41

B

Biospecifics

BSTC

+0.15%
88.53
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.